---
schema_version: "secwatch.filing_event.v1"
accession: "0000320017-24-000013"
form_type: "8-K"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:55:16.345832+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lisata appoints James Nisco as SVP, Finance & Treasury and CAO

## Summary
- James Nisco appointed Senior Vice President, Finance and Treasury and Chief Accounting Officer effective April 15, 2024.
- Nisco will serve as principal financial officer and principal accounting officer.
- Annual base salary set at $350,000 with a short-term incentive bonus target of 35% of base.
- Nisco previously served as Vice President of Finance & Treasury since August 2020, an internal promotion.
- No family relationships with directors/executives; no reportable transactions under Item 404.

## SEC filing metadata
- accession: 0000320017-24-000013
- form_type: 8-K
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/0000320017-24-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/clbs-20240415.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000320017-24-000013
- JSON: https://secwatch.observer/filing/0000320017-24-000013.json
- Plain text: https://secwatch.observer/filing/0000320017-24-000013.txt

## Key facts
- Executive change
  James Nisco was appointed as Senior Vice President, Finance and Treasury and Chief Accounting Officer at LISATA THERAPEUTICS, INC..
  - Action: appointed
  - Role: Senior Vice President, Finance and Treasury and Chief Accounting Officer
  source text: On April 15, 2024 (the “Effective Date”), the Board of Directors (the “Board”) of Lisata Therapeutics, Inc. (the “Company”) appointed James Nisco as the Company’s Senior Vice President, Finance and Treasury and Chief Accounting Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/0000320017-24-000013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.